Aspen Pharmacare

Error creating thumbnail:

Aspen Pharmacare logo

Aspen Pharmacare is a multinational pharmaceutical company headquartered in Durban, South Africa. It is the largest drug company in Africa and has a significant presence in both emerging and developed markets. Aspen Pharmacare is known for its diverse portfolio of products, including branded and generic pharmaceuticals, as well as over-the-counter (OTC) medicines.

History

Aspen Pharmacare was founded in 1850 as a small business in Port Elizabeth, South Africa. Over the years, it has grown through strategic acquisitions and partnerships. In 1999, Aspen acquired the South African Druggists, which significantly expanded its product range and market reach. The company continued to grow, acquiring several other pharmaceutical companies and product lines, including the acquisition of the global rights to certain products from GlaxoSmithKline in 2009.

Operations

Aspen Pharmacare operates in more than 50 countries and has over 60 manufacturing facilities across the globe. The company's operations are divided into several business segments, including:

• Branded Pharmaceuticals
• Generic Pharmaceuticals
• Over-the-Counter (OTC) Medicines
• Active Pharmaceutical Ingredients (APIs)

Products

Aspen's product portfolio includes a wide range of therapeutic categories such as:

• Cardiovascular
• Central nervous system
• Gastroenterology
• HIV/AIDS
• Oncology
• Women's health

Research and Development

Aspen Pharmacare invests significantly in research and development (R&D) to innovate and improve its product offerings. The company has several R&D facilities worldwide, focusing on developing new formulations and improving existing products.

Corporate Social Responsibility

Aspen is committed to corporate social responsibility (CSR) and sustainability. The company engages in various initiatives aimed at improving healthcare access, supporting local communities, and reducing its environmental footprint.

Key People

• Stephen Saad - Co-founder and Group Chief Executive
• Gus Attridge - Co-founder and Deputy Group Chief Executive

See Also

• Pharmaceutical industry
• Generic drug
• Over-the-counter drug
• Active pharmaceutical ingredient
• GlaxoSmithKline